Roper Technologies, Inc. (ROP)
After hours:
Chart Events
Performance Outlook
| Previous Close | 394.65 |
| Open | 394.84 |
| Bid | 401.23 x 800 |
| Ask | 401.15 x 900 |
| Day's Range | 393.83 - 401.78 |
| 52 Week Range | 369.51 - 505.00 |
| Volume | |
| Avg. Volume | 692,072 |
| Market Cap | 42.436B |
| Beta (5Y Monthly) | 1.01 |
| PE Ratio (TTM) | 42.72 |
| EPS (TTM) | 9.38 |
| Earnings Date | Jul 21, 2022 - Jul 25, 2022 |
| Forward Dividend & Yield | 2.48 (0.63%) |
| Ex-Dividend Date | Jul 07, 2022 |
| 1y Target Est | 494.54 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for ROP
Related Research
- Roper Technologies, Inc.Analyst Report: Roper Technologies, Inc.Roper is a diversified technology company that operates four segments: application software; network software and systems; measurement and analytical solutions; and process technologies. The firm’s culture emphasizes acquiring asset-light, cash-generative businesses. Roper then reinvests this excess cash in businesses that yield incrementally higher rates of return. While the businesses are managed in a decentralized manner, Roper does not passively manage its portfolio. Instead, Roper manages its businesses through the Socratic method and empowers decision-makers through group executive coaching. Roper has now rotated a clear majority of its business from legacy industrial products into technology software in mature, niche markets with large quantities of deferred revenue.RatingFair ValueEconomic Moatlast monthMorningstar
- GlobeNewswire
Roper Technologies Announces Updated Segment Structure
SARASOTA, Fla., June 30, 2022 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (NYSE: ROP) announced today that it has updated its reportable segments. The three updated reportable segments are as follows: Application Software – Aderant, CBORD, CliniSys, Data Innovations, Deltek, IntelliTrans, PowerPlan, Strata, Vertafore Network Software – ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP, SoftWriters Technology Enabled Products – CIVCO Medical Solutions, FMI, Inovonics,
- Zacks
MRC Global (MRC) Displays Bright Prospects, Risks Persist
MRC Global (MRC) stands to benefit from strength across its end markets, lucrative contracts and shareholder-friendly policies. However, cost woes and supply-chain issues weigh on it.
- Zacks
End Markets Aid Applied Industrial (AIT) Despite Challenges
Applied Industrial (AIT) is poised to benefit from strength in its end markets, acquired assets and shareholder-friendly policies. However, escalating costs and expenses weigh on it.
